We propose a model in which this Y304 phosphorylation drives CcO dimer formation as a downstream effect of inflammatory signaling that is associated with diabetes, leading to a profound reduction of CcO enzymatic activity in (pre-)diabetic liver tissue (Figure 7). This evidence concerns the gene RYR1 and diabetes mellitus.